BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 156670)

  • 1. [Cerebral degeneration in Down's syndrome].
    Hirabayashi K; Ikeda K; Shimokawa K; Orthner H
    Folia Psychiatr Neurol Jpn; 1979; 33(1):81-96. PubMed ID: 156670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topographic relationship between neurofibrillary change and acetylcholinesterase rich neurons in the upper brain stem of patients with senile dementia of the Alzheimer's type and Down's syndrome.
    Shortridge BA; Vogel FS; Burger PC
    Clin Neuropathol; 1985; 4(6):227-37. PubMed ID: 2934202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
    Teipel SJ; Alexander GE; Schapiro MB; Möller HJ; Rapoport SI; Hampel H
    Brain; 2004 Apr; 127(Pt 4):811-24. PubMed ID: 14985261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological studies on senile plaques in brains of patients with Down's syndrome.
    Fukuoka Y; Fujita T; Ito H
    Kobe J Med Sci; 1990 Dec; 36(5-6):153-71. PubMed ID: 1708000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down's syndrome and Alzheimer's dementia: defining an association.
    Heston LL
    Psychiatr Dev; 1984; 2(4):287-94. PubMed ID: 6241313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down's syndrome in middle age. Topographical distribution and immunoreactivity of brain lesions in an autopsied patient.
    Yoshimura N; Kubota S; Fukushima Y; Kudo H; Ishigaki H; Yoshida Y
    Acta Pathol Jpn; 1990 Oct; 40(10):735-43. PubMed ID: 1963256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
    Ikeda S; Allsop D; Glenner GG
    Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral amyloid angiopathy in Down's syndrome.
    Belza MG; Urich H
    Clin Neuropathol; 1986; 5(6):257-60. PubMed ID: 2949903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of the nucleus basalis in Down's syndrome.
    Casanova MF; Walker LC; Whitehouse PJ; Price DL
    Ann Neurol; 1985 Sep; 18(3):310-3. PubMed ID: 2932050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology.
    Margallo-Lana ML; Moore PB; Kay DW; Perry RH; Reid BE; Berney TP; Tyrer SP
    J Intellect Disabil Res; 2007 Jun; 51(Pt. 6):463-77. PubMed ID: 17493029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders.
    Joachim CL; Morris JH; Kosik KS; Selkoe DJ
    Ann Neurol; 1987 Oct; 22(4):514-20. PubMed ID: 2963585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.
    Joachim CL; Mori H; Selkoe DJ
    Nature; 1989 Sep; 341(6239):226-30. PubMed ID: 2528696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alzheimer's disease and Down's syndrome. Some recent etiopathogenic data].
    Golaz J; Charnay Y; Vallet P; Bouras C
    Encephale; 1991; 17(1):29-31. PubMed ID: 1669030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropathologic investigation in autopsies with special emphasis on findings in Alzheimer's disease].
    Leel-Ossy L; Kindler M; Szucs I; Schwarcz T
    Ideggyogy Sz; 2006 May; 59(5-6):164-77. PubMed ID: 16786711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Down's syndrome and dementia].
    Parajuá-Pozo JL; Casis-Arguea S
    Rev Neurol; 2000 Jul 16-31; 31(2):126-8. PubMed ID: 10951667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile Alzheimer's disease with cerebellar involvement.
    Vakili ST; Muller J
    Arch Pathol Lab Med; 1987 May; 111(5):480-2. PubMed ID: 3566478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
    Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cerebral amyloid angiopathy, recurrent intracerebral haemorrhages and Down's syndrome].
    Romero López J; Rivas Infante E; Maciñeiras Montero JL; Montero Carretero MJ
    Neurologia; 2006 Dec; 21(10):729-32. PubMed ID: 17106827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathological findings in a case of coexistent progressive supranuclear palsy and Alzheimer's disease.
    Milder DG; Elliott CF; Evans WA
    Clin Exp Neurol; 1984; 20():181-7. PubMed ID: 6568940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21).
    Raghavan R; Khin-Nu C; Brown AG; Day KA; Tyrer SP; Ince PG; Perry EK; Perry RH
    Neuroreport; 1994 Jun; 5(11):1393-6. PubMed ID: 7919207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.